Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carol J. Braun"'
Autor:
Nikki Adetoro, Paul Nyirjesy, Carol J. Braun, Franklin G. Morgan, Arthur S. Waldbaum, Sharon L. Hillier, Jane R. Schwebke
Publikováno v:
Obstetrics and gynecology. 130(2)
To evaluate secnidazole as a single oral dose treatment for bacterial vaginosis in a phase 2 randomized, double-blind, placebo-controlled study.In a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study, women with bacterial vagin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faea4581151893ee5dc6cbdddedbd544
https://pubmed.ncbi.nlm.nih.gov/28697102
https://pubmed.ncbi.nlm.nih.gov/28697102
Publikováno v:
Advances in therapy. 33(12)
Bacterial vaginosis (BV) is a serious infection that is the most common vaginal infection in women of childbearing potential. SYM-1219 is a novel, granule formulation containing 2 g of secnidazole that is being developed as a single, oral dose to tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::656b1fce5d0885a940dea2b55efeabfd
https://pubmed.ncbi.nlm.nih.gov/27744624
https://pubmed.ncbi.nlm.nih.gov/27744624
Autor:
D. A. Yardley, Miranda Rees, Peter Ordentlich, Suzanne F. Jones, Helen S. Pentikis, Carol J Braun, Jeannette Lynne Hasapidis, Howard A. Burris
Publikováno v:
Journal of Clinical Oncology. 32:591-591
591 Background: Entinostat (ENT) is an oral, class 1 isoform selective histone deacetylase inhibitor shown to extend progression free and overall survival when combined with exemestane (EXE) in post-menopausal women with estrogen receptor positive (E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e638e71ad162264160f3d21522375e2
https://doi.org/10.1200/jco.2014.32.15_suppl.591
https://doi.org/10.1200/jco.2014.32.15_suppl.591